Equity
€14.1m ▲ 20.5%
NEOGEN has made a profit without a break since 2021.
NEOGEN
Lifetime
18 annual accounts with figures on one time axis, 33 filings since 1992peak €2.8m (2023)
€2.1m▼ 24.7%
lowest -€2.0m (2020)
€2.4m▼ 20.8%
peak €14.1m (2025)
€14.1m▲ 20.5%
€3.7m▲ 4.7%
peak 2 FTE (2012)
-not published
Board10 names since 2020
2 directorsCellular Consulting BO and 1 other
Owners2 names in the annual accounts
consolidatesA.forall Group
Documentsfilings and deeds
27-10-202688 days late
2025financial year
Gross margin from €2.8m to €2.1m2 directors reappointed 30-10Equity from €11.7m to €14.1mCash from €48,607 to €31,419
Key points
from the 2025 annual accountsTurnover
≈ €3.6m estimated
The accounts state no turnover.
Investments
€57,675 0.2 × depreciation
Green is investment, beige is depreciation.
Liquidity
15.57 was 41.91 in 2024
Short-term debts rose from €331,329 to €1.1m.
Filings
33 annual accounts 34 filings, 88 days
Latest accounts filed late: after the legal deadline.
Board
1 joined · 1 left
Board changed. Latest change 01-01-2026 · 2 in office.
Checked score
91
Excellent
Financially stronger than 81% of companies in pharmaceuticals (NACE 21)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.1% across 26 companies (NACE 21, medium-sized).
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%lowest value
01-2025: < 0.1%● unchanged vs 12-2024lowest value
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: 0.1%▲ +0.1 percentage points vs 06-2025
08-2025: 0.2%▲ +0.1 percentage points vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.2%● unchanged vs 01-2026
03-2026: 0.2%● unchanged vs 02-2026
04-2026: 0.2%● unchanged vs 03-2026
05-2026: 0.2%● unchanged vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026
07-2026: 0.2%● unchanged vs 06-2026
08-2026: 0.3%▲ +0.1 percentage points vs 07-2026
09-2026: 0.4%▲ +0.1 percentage points vs 08-2026highest value
10-2026: 0.2%▼ -0.2 percentage points vs 09-2026
11-2026: 0.2%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Liquidity: current ratio 15.57, cash €31,419
Last filed accounts filed 88 days late; 2 of the last 3 accounts late
lowers risk
Founded in 1991
Legal form: public limited company
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21). It does better than 91% of them on solvency, 76% on liquidity, 85% on profitability and 73% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 1,579 companies had the same profile as NEOGEN has now. Each dot stands for 4 companies, two years later.
96.6%
were still trading
3.2%
stopped another way
0.1%
went bankrupt
That fits the bankruptcy probability of NEOGEN itself: 0.2% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,579 companies, not a prediction for NEOGEN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €1,250,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 15.57 (41.91 in 2024), above the usual 1.5. Short-term debt is 6.1% and cash 0.2% of total assets. 20.7% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 88 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-10-2026, 88 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
88 days late
2024
56 days late
2023
22 days early
2022
29 days late
2021
26 days early
2020
40 days late
2019
17 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 21 days after the deadline. In the sector (NACE 21), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 August (4 of the last 5 accounts filed within 55 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
LA
LMDC Advisory s.r.o.
Daily manager, Libor Matyásek
CC
Cellular Consulting BO
Director, since 04-09-2025
- A.forall Development 100%equity €37.6m (2025) · 2025 annual accounts of A.forall Development
- A forall Group NV consolidatesannual accounts 2025
Recent changes
New day-to-day manager
LMDC Advisory s.r.o. appointed, LMDC GmbH resigned · Permanent representatives: Libor Matyásek and Erik Voets · General meeting of 10-12-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0445922856
2 directors reappointed
LMDC GmbH and Cellular Consulting, LDA · Permanent representatives: Libor Matyasek and Bruno Febra · General meeting of 04-09-2025 · Gazette deed
1 director appointed, 1 resignation, 1 statutory auditor reappointed
Reappointment: Deloitte Bedrijfsrevisoren BV (statutory auditor) · Resignation: HFS BV (day-to-day manager) · Permanent representatives: Ivo Peeters and Libor Matyásek · General meeting of 02-07-2024 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| NEOGEN Anderlecht | €17.8m | €2.1m | 79.3% | - |
| BETAPLUS PHARMA Woluwe-Saint-Lambert | €24.9m | €2.7m | 89.8% | 11.3 |
| DEBA PHARMA Kortrijk | €6.6m | €2.9m | 94.4% | 1.2 |
| BIVIT Wevelgem | €4.4m | €3.1m | 17.8% | 23.5 |
| Advanced Practical Diagnostics Turnhout | €4.5m | €2.3m | 55.5% | 12.3 |
| TRUVION HEALTHCARE Temse | €3.2m | €1.6m | 41.4% | 10.1 |
| ASTEL MEDICA Neupré | €2.6m | €2.1m | 53.2% | 14.6 |
These companies have the same main activity as NEOGEN: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201). They are comparable in size and age: total assets between €2.6m and €25m, founded between 1974 and 2008.
Official details
Source: KBO- Status
- Active since 09-12-1991Normal situation
- Registered office
- 10 active companies are registered at this addressSource: KBO register, as of 8 November 2026.
- Activity
- Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21201
- Joint committee
- 207White-collar workers in the chemical industry · annual accounts 2025
- Establishment unit
- 2.055.632.3141070 Anderlecht, since 07-01-1992
- Financial year end
- 31 December
- Peppol
- Reachable since 29-12-2025
Companies linked to NEOGEN
Parent and group
Insights on NEOGEN
NEOGEN has existed since 1991. The present size dates from 2020. The gross margin rose that year from €549,879 to €1.4m.
A.forall Development holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about NEOGEN
- What is the company number of NEOGEN?
- The company number of NEOGEN is 0445.922.856. The VAT number is the same number with BE in front: BE 0445.922.856.
- Where is NEOGEN based?
- The registered office is at Marie Curiesquare 50, 1070 Anderlecht.Company details
- What does NEOGEN do?
- According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201).
- What is the legal form of NEOGEN?
- NEOGEN is a public limited company (NV).
- When was NEOGEN founded?
- NEOGEN was founded on 09-12-1991.
- Is NEOGEN still active?
- Yes, NEOGEN is an active enterprise in the KBO register.
- How many employees does NEOGEN have?
- NEOGEN had an average of 1 full-time equivalents in financial year 2019, according to the filed annual accounts.Financials
- Which joint committee does NEOGEN fall under?
- In its 2025 annual accounts, NEOGEN states joint committee 207 (White-collar workers in the chemical industry).
- What is the turnover of NEOGEN?
- The turnover in financial year 2025 is ≈ €3.6m. This figure is estimated from the gross margin of €2.1m and 1,585 comparable companies of the same size. It probably lies between €2.4m and €5.9m. It is a rough estimate. In financial year 2020 turnover was €2.4m.
- Is NEOGEN profitable?
- In financial year 2025, NEOGEN made a profit of €2.4m.
- Where can I find the annual accounts of NEOGEN?
- NEOGEN filed 34 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of NEOGEN due?
- NEOGEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See the other companies in the same group.A.forall Group · 16 companies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.